Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Red blood cell membrane proteins are a large, heterogeneous group of proteins embedded in or associated with the lipid bilayer of the erythrocyte membrane. They are essential for the durability, flexibility, and durability of the red blood cell, enabling deformability for capillary passage and resistance to mechanical stress[1][7][8]. There are more than 50 well-characterized proteins, commonly grouped by function: - **Structural proteins**: (e.g., spectrin, ankyrin, protein 4.1R, actin) form the membrane skeleton, crucial for shape and mechanical properties[1][7]. - **Integral membrane proteins**: (e.g., band 3, glycophorins) span the bilayer, providing anchor points for the cytoskeleton and serving as blood group antigens (ABO, Rh, etc.)[3][5][8]. - **Transporters and channels**: (e.g., band 3 for anion exchange, Glut1 for glucose, aquaporin 1 for water, RhAG for gas) regulate exchange of ions, nutrients, and gases[3][8]. - **Adhesion molecules and receptors**: (e.g., ICAM-4, Duffy, Lu) mediate cell-cell interactions and signal transduction[2][3]. Disorders of these proteins contribute to red cell membrane diseases such as hereditary spherocytosis and elliptocytosis, and variation between individuals underlies blood group diversity, impacting transfusion medicine[2][5][8]. **Note:** "Red blood cell membrane protein" is a broad collective category, not a single, specific molecular target. Instead, it includes many structurally and functionally distinct proteins, some of which (such as Band 3 or the Rh protein) are individually considered therapeutic or diagnostic targets. For highly specific information, a particular protein (e.g., "Band 3 anion transporter" or "Rh antigen") should be named[2][3][7][8].
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Red blood cell membrane protein (null).